Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

All Specialties

OpiCalc Logo
FavoritesSpecialtiesDrugsGuidelinesMost Used
FavesSpecsDrugsGuidesTop
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2018-2026

•

All Rights Reserved

Registry Hub

Therapeutic Classification

androgen receptor inhibitor Registry

Clinical reference for androgen receptor inhibitor medications. Access safety monographs, dosing adjustments, and drug-drug interactions for all registered brand names and generics in this class.

Registered Medications (androgen receptor inhibitor)

This therapeutic registry is dynamically synthesized from professional clinical sources. Listing of a medication does not imply equivalence; refer to individual monographs for head-to-head pharmacological data.

MedicationTherapeutic ClassMaternal Safety

APALUTAMIDE

Comprehensive clinical and safety monograph for APALUTAMIDE (APALUTAMIDE).

Androgen Receptor Inhibitor

caution

ENZALUTAMIDE

Strong CYP2C8 inhibitors may increase levels and inducers may decrease levels Can cause seizures and posterior reversible encephalopathy syndrome (PRES).

Androgen Receptor Inhibitor

avoid

ERLEADA

Comprehensive clinical and safety monograph for ERLEADA (ERLEADA).

Androgen Receptor Inhibitor Antineoplastic

caution

NUBEQA

Comprehensive clinical and safety monograph for NUBEQA (NUBEQA).

Androgen Receptor Inhibitor

caution

WINLEVI

Comprehensive clinical and safety monograph for WINLEVI (WINLEVI).

Topical Androgen Receptor Inhibitor

caution